Skip to content

Clinical trials

Phase 3 Crohn Disease trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Crohn Disease Phase: Phase 3 Country / region: South Korea Clear all

55 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20092
20102
20116
20153
20164
20176
201810
20192
20202
20212
20222
20233
20245
20254
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed19
Recruiting14
Terminated12
Active, not recruiting7
Unknown status2
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AbbVie10
Takeda8
Celgene7
Janssen Research & Development, LLC7
Eli Lilly and Company4
GlaxoSmithKline4
Shire3
Hoffmann-La Roche2
Lakefront Biotherapeutics NV2
Samsung Medical Center2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Crohn Disease55
Colitis, Ulcerative9
Inflammatory Bowel Diseases9
Colitis3
Arthritis, Juvenile1
Arthritis, Psoriatic1
Gastroenteritis1
Irritable Bowel Syndrome1

Trials

Showing 1 to 25 of 55. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.